INDBInternet News Database 2.5 Updated 2 min ago · 397 sources Show or hide images Light or dark

Radioactive Iodine Shows Limited Benefit in Tall Cell Cancer

Save Like Comments Compare coverage

Summary

No remissions or partial responses are observed over 4 years among patients with high-risk tall cell variant papillary thyroid cancer treated with radioactive iodine.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Radioactive Iodine Shows Limited Benefit in Tall Cell Cancer

    No remissions or partial responses are observed over 4 years among patients with high-risk tall cell variant papillary thyroid cancer treated with radioactive iodine.

Comments

Comments need JavaScript.